Baca, Manuel,Drabic, Stacey,Emtage, Peter,Herbst, Ronald
申请号：
AU2017264944
公开号：
AU2017264944A1
申请日:
2017.05.12
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Provided herein is a CD40L-Fc fusion protein and methods of using the fusion protein in the treatment of cancer comprising administering the CD40L-Fc fusion protein or the CD40L-Fc fusion protein in combination with one or more immune checkpoint inhibitors (e.g., an anti-CTLA4 antibody, anti-PD-Ll antibody).
